Insider · CIK 0001374150
DOMAIN PARTERS VII L P
Reports to the SEC for 11 companies · PRINCETON, NJ
Transactions
50
Companies
11
Filings
10
CIK
0001374150
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2019-08-06 | HINDVyome Holdings, Inc · Warrants to Purchase Common StockP Purchase | +$750K |
| 2019-08-06 | HINDVyome Holdings, IncP Purchase | +$1M |
| 2018-08-23 | HINDVyome Holdings, IncP Purchase | +$3M |
| 2016-11-01 | Tobira Therapeutics, Inc.U Disposition from Tender | −$101M |
| 2016-10-12 | HINDVyome Holdings, Inc · Series B Preferred StockC Conversion | — |
| 2016-10-12 | HINDVyome Holdings, IncC Conversion | — |
| 2016-10-12 | HINDVyome Holdings, Inc · Series D Preferred StockC Conversion | — |
| 2016-10-12 | HINDVyome Holdings, Inc · Series E Preferred StockC Conversion | — |
| 2016-10-12 | HINDVyome Holdings, Inc · Series C Preferred StockC Conversion | — |
| 2016-10-12 | HINDVyome Holdings, Inc · Series A Preferred StockC Conversion | — |
| 2016-05-26 | EVOKEvoke Pharma IncS Sale | −$1.62M |
| 2016-04-27 | EVOKEvoke Pharma IncS Sale | −$18.1K |
| 2016-04-25 | EVOKEvoke Pharma IncS Sale | −$7,758.4 |
| 2016-04-20 | EVOKEvoke Pharma IncS Sale | −$23.4K |
| 2016-04-19 | EVOKEvoke Pharma IncS Sale | −$199K |
| 2016-04-11 | EVOKEvoke Pharma IncS Sale | −$22.7K |
| 2016-04-08 | EVOKEvoke Pharma IncS Sale | −$77.9K |
| 2016-04-07 | EVOKEvoke Pharma IncS Sale | −$146K |
| 2016-04-06 | EVOKEvoke Pharma IncS Sale | −$45.3K |
| 2015-08-18 | EVOKEvoke Pharma IncS Sale | −$83.1K |
| 2015-05-04 | Tobira Therapeutics, Inc.P Purchase | +$2.95M |
| 2015-04-16 | EVOKEvoke Pharma IncS Sale | −$229K |
| 2015-04-15 | EVOKEvoke Pharma IncS Sale | −$60K |
| 2015-04-14 | EVOKEvoke Pharma IncS Sale | −$76.5K |
| 2015-03-20 | ESPREsperion Therapeutics, Inc.J Other | — |
| 2014-11-25 | EVFMEvofem Biosciences, Inc.F Tax Payment | −$1.42M |
| 2014-11-25 | EVFMEvofem Biosciences, Inc.M Exercise/Conversion | +$1.42M |
| 2014-11-25 | EVFMEvofem Biosciences, Inc.F Tax Payment | −$787K |
| 2014-11-25 | EVFMEvofem Biosciences, Inc. · Series C Preferred Stock Warrant (Right to Buy)M Exercise/Conversion | — |
| 2014-11-25 | EVFMEvofem Biosciences, Inc.P Purchase | +$980K |
| 2014-11-25 | EVFMEvofem Biosciences, Inc. · Series B-2 Preferred Stock Warrant (Right to Buy)M Exercise/Conversion | — |
| 2014-11-25 | EVFMEvofem Biosciences, Inc.M Exercise/Conversion | +$787K |
| 2014-11-25 | EVFMEvofem Biosciences, Inc.C Conversion | — |
| 2014-11-25 | EVFMEvofem Biosciences, Inc. · Series B-2 Preferred StockC Conversion | — |
| 2014-11-25 | EVFMEvofem Biosciences, Inc. · Series B Preferred StockC Conversion | — |
| 2014-11-25 | EVFMEvofem Biosciences, Inc. · Series A Preferred StockC Conversion | — |
| 2014-11-25 | EVFMEvofem Biosciences, Inc.F Tax Payment | −$1.42M |
| 2014-11-25 | EVFMEvofem Biosciences, Inc.M Exercise/Conversion | +$1.42M |
| 2014-11-25 | EVFMEvofem Biosciences, Inc.F Tax Payment | −$787K |
| 2014-11-25 | EVFMEvofem Biosciences, Inc.M Exercise/Conversion | +$787K |
| 2014-11-25 | EVFMEvofem Biosciences, Inc.C Conversion | — |
| 2014-11-25 | EVFMEvofem Biosciences, Inc.P Purchase | +$980K |
| 2014-11-25 | EVFMEvofem Biosciences, Inc. · Series C Preferred Stock Warrant (Right to Buy)M Exercise/Conversion | — |
| 2014-11-25 | EVFMEvofem Biosciences, Inc. · Series B-2 Preferred Stock Warrant (Right to Buy)M Exercise/Conversion | — |
| 2014-11-25 | EVFMEvofem Biosciences, Inc. · Series C Preferred StockC Conversion | — |
| 2014-11-25 | EVFMEvofem Biosciences, Inc. · Series C Preferred StockC Conversion | — |
| 2014-11-25 | EVFMEvofem Biosciences, Inc. · Series B-2 Preferred StockC Conversion | — |
| 2014-11-25 | EVFMEvofem Biosciences, Inc. · Series B Preferred StockC Conversion | — |
| 2014-11-25 | EVFMEvofem Biosciences, Inc. · Series A Preferred StockC Conversion | — |
| 2014-10-21 | ESPREsperion Therapeutics, Inc.P Purchase | +$10M |
Recent filings
- 4DOMAIN PARTERS VII L P0000904454-19-000600SEC(opens sec.gov)
- 4DOMAIN PARTERS VII L P0000904454-18-000526SEC(opens sec.gov)
- 4Tobira Therapeutics, Inc.0000904454-16-001531SEC(opens sec.gov)
- 4OBALON THERAPEUTICS INC0000904454-16-001500SEC(opens sec.gov)
- 4Evoke Pharma Inc0000904454-16-001235SEC(opens sec.gov)
- 4Evoke Pharma Inc0000904454-16-001187SEC(opens sec.gov)
- 4Evoke Pharma Inc0000904454-16-001170SEC(opens sec.gov)
- 4Evoke Pharma Inc0000904454-16-001164SEC(opens sec.gov)
- 4Evoke Pharma Inc0000904454-16-001154SEC(opens sec.gov)
- 4Evoke Pharma Inc0000904454-15-000536SEC(opens sec.gov)
Companies
- Achaogen, Inc.10% Owner
- CADENCE PHARMACEUTICALS INC10% Owner
- Clovis Oncology, Inc.10% Owner
- Esperion Therapeutics, Inc.10% OwnerESPR
- Evofem Biosciences, Inc.10% OwnerEVFM
- Evoke Pharma Inc10% OwnerEVOK
- Orexigen Therapeutics, Inc.10% Owner
- TANDEM DIABETES CARE INC10% OwnerTNDM
- Tobira Therapeutics, Inc.10% Owner
- Vyome Holdings, Inc10% OwnerHIND
- ZOGENIX, INC.10% Owner
Address
C/O DOMAIN ASSOCIATES, LLC ONE PALMER SQUARE
PRINCETON, NJ, 08542